β-neoendorphin (Human) [1278]



β-neoendorphin (Human)


SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
InChIKey RTXIYIQLESPXIV-VLOLPVCOSA-N
Sequence YGGFLRKYP
HELM PEPTIDE1{Y.G.G.F.L.R.K.Y.P}$$$$

Chemical Properties

Hydrogen bond acceptors 14
Hydrogen bond donors 14
Rotatable bonds 32
Log P -1.586
Molecular weight (Da) 1099.6
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

β-neoendorphin (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 6
Phase IV 12


Sankey plot


Drug Information

Target Disease
Gene Protein Receptor family Ligand type Class Name Phase ICD11 ATC Association score